A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus

BACKGROUND: Thiazolidinediones (TZDs) have been associated with various safety concerns including weight gain, bladder cancer, and congestive heart failure (CHF). This study evaluated the efficacy and safety of lobeglitazone, a novel TZD in patients with type 2 diabetes mellitus (T2DM) in real pract...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Bo-Yeon, Kwon, Hyuk-Sang, Kim, Suk Kyeong, Noh, Jung-Hyun, Park, Cheol-Young, Park, Hyeong-Kyu, Song, Kee-Ho, Won, Jong Chul, Yu, Jae Myung, Lee, Mi Young, Lee, Jae Hyuk, Lim, Soo, Chun, Sung Wan, Jeong, In-Kyung, Chung, Choon Hee, Han, Seung Jin, Kim, Hee-Seok, Min, Ju-Young, Kim, Sungrae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723193/
https://www.ncbi.nlm.nih.gov/pubmed/35255547
http://dx.doi.org/10.4093/dmj.2021.0264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723193/
https://www.ncbi.nlm.nih.gov/pubmed/35255547
http://dx.doi.org/10.4093/dmj.2021.0264

Ejemplares similares